| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |